Clinical Trials Browser

Phase 2 × Non-Muscle Invasive Bladder Neoplasms × dodecyl maltoside × Clear all

NCT07283835 2026-04-23

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ

NCT04387461 2024-09-25

CORE-001

Phase 2 Completed

Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ